For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $48.02 in the prior trading day, Bright Minds Biosciences Inc (NASDAQ: DRUG) closed at $47.17, down -1.76%. In other words, the price has decreased by -$1.76 from its previous closing price. On the day, 2.25 million shares were traded. DRUG stock price reached its highest trading level at $50.0 during the session, while it also had its lowest trading level at $41.425.
Ratios:
Our goal is to gain a better understanding of DRUG by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 35.08 and its Current Ratio is at 35.08. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 15 ’24 when Cormorant Asset Management, LP bought 372,591 shares for $5.53 per share. The transaction valued at 2,061,574 led to the insider holds 825,000 shares of the business.
Cormorant Asset Management, LP bought 50,000 shares of DRUG for $1,172,813 on Oct 16 ’24. The 10% Owner now owns 875,000 shares after completing the transaction at $23.46 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DRUG now has a Market Capitalization of 214483968 and an Enterprise Value of 204405280.
Stock Price History:
Over the past 52 weeks, DRUG has reached a high of $79.02, while it has fallen to a 52-week low of $0.93. The 50-Day Moving Average of the stock is 733.80%, while the 200-Day Moving Average is calculated to be 1835.07%.
Shares Statistics:
The stock has traded on average 2.81M shares per day over the past 3-months and 17678260 shares per day over the last 10 days, according to various share statistics. A total of 3.77M shares are outstanding, with a floating share count of 3.08M. Insiders hold about 31.00% of the company’s shares, while institutions hold 33.32% stake in the company. Shares short for DRUG as of 1727654400 were 85132 with a Short Ratio of 0.03, compared to 1724976000 on 181456. Therefore, it implies a Short% of Shares Outstanding of 85132 and a Short% of Float of 2.3800000000000003.
